These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25812126)

  • 21. Impulsivity in anxiety disorder patients: is it related to comorbid cyclothymia?
    Perugi G; Del Carlo A; Benvenuti M; Fornaro M; Toni C; Akiskal K; Dell'Osso L; Akiskal H
    J Affect Disord; 2011 Oct; 133(3):600-6. PubMed ID: 21665290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features associated with impulse control disorders in Parkinson disease.
    Pontone G; Williams JR; Bassett SS; Marsh L
    Neurology; 2006 Oct; 67(7):1258-61. PubMed ID: 17030761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impulse Control Disorders - The Continuum Hypothesis.
    Stenberg G
    J Parkinsons Dis; 2016; 6(1):67-75. PubMed ID: 27031861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perceptual decision-making in patients with Parkinson's disease.
    Djamshidian A; O'Sullivan SS; Lawrence AD; Foltynie T; Aviles-Olmos I; Magdalinou N; Tomassini A; Warner TT; Lees AJ; Averbeck BB
    J Psychopharmacol; 2014 Dec; 28(12):1149-54. PubMed ID: 25237123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biogenetic temperament and character and attention deficit hyperactivity disorder in Korean children.
    Yoo HJ; Kim M; Ha JH; Chung A; Sim ME; Kim SJ; Lyoo IK
    Psychopathology; 2006; 39(1):25-31. PubMed ID: 16282716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between morningness-eveningness and temperament and character in community-dwelling Korean adults.
    Lee S; Park JE; Cho SJ; Cho IH; Lee YJ; Kim SJ
    Asia Pac Psychiatry; 2014 Mar; 6(1):77-82. PubMed ID: 23857957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of type 1 cannabinoid receptor availability in the human brain to novelty-seeking temperament.
    Van Laere K; Goffin K; Bormans G; Casteels C; Mortelmans L; de Hoon J; Grachev I; Vandenbulcke M; Pieters G
    Arch Gen Psychiatry; 2009 Feb; 66(2):196-204. PubMed ID: 19188542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attentional bias as trait: correlations with novelty seeking.
    Tomer R
    Neuropsychologia; 2008; 46(7):2064-70. PubMed ID: 18342343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Multicenter Comparative Study of Impulse Control Disorder in Latin American Patients With Parkinson Disease.
    Ramírez Gómez CC; Serrano Dueñas M; Bernal O; Araoz N; Sáenz Farret M; Aldinio V; Montilla V; Micheli F
    Clin Neuropharmacol; 2017; 40(2):51-55. PubMed ID: 28288482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Betting on dopamine.
    Stein DJ; Grant JE
    CNS Spectr; 2005 Apr; 10(4):268-70. PubMed ID: 15788954
    [No Abstract]   [Full Text] [Related]  

  • 31. Impulsive compulsive behaviours in Parkinson's disease: patients' versus caregivers' perceptions.
    Ricciardi L; Demartini B; Pomponi M; Ricciardi D; Morabito B; Renna R; Bernabei R; Bentivoglio AR
    J Neurol; 2016 May; 263(5):1019-1021. PubMed ID: 26964540
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of impulse control disorders in Parkinson's disease: Practical considerations and future directions.
    Ramirez-Zamora A; Gee L; Boyd J; Biller J
    Expert Rev Neurother; 2016; 16(4):389-99. PubMed ID: 26923084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
    Seeman P
    Synapse; 2015 Apr; 69(4):183-9. PubMed ID: 25645960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
    Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine agonist withdrawal syndrome: A comprehensive review.
    Yu XX; Fernandez HH
    J Neurol Sci; 2017 Mar; 374():53-55. PubMed ID: 28104232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists.
    Rizos A; Sauerbier A; Antonini A; Weintraub D; Martinez-Martin P; Kessel B; Henriksen T; Falup-Pecurariu C; Silverdale M; Durner G; Røkenes Karlsen K; Grilo M; Odin P; Chaudhuri KR;
    Eur J Neurol; 2016 Aug; 23(8):1255-61. PubMed ID: 27170229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temperament and character profiles and the dopamine D4 receptor gene in ADHD.
    Lynn DE; Lubke G; Yang M; McCracken JT; McGough JJ; Ishii J; Loo SK; Nelson SF; Smalley SL
    Am J Psychiatry; 2005 May; 162(5):906-13. PubMed ID: 15863792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease.
    Tessitore A; De Micco R; Giordano A; di Nardo F; Caiazzo G; Siciliano M; De Stefano M; Russo A; Esposito F; Tedeschi G
    Mov Disord; 2017 Dec; 32(12):1710-1719. PubMed ID: 28949049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
    Hanna-Pladdy B; Pahwa R; Lyons KE
    J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The high-novelty-seeking, impulsive subtype of generalized social anxiety disorder.
    Kashdan TB; Hofmann SG
    Depress Anxiety; 2008; 25(6):535-41. PubMed ID: 17935217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.